Navigation LinksTop Biology NewsTop Medical NewsTop Biology TechnologyTop Medical Technology


Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care

11/7/2009

0

GOOD
MIAMI BEACH, Fla., Nov. 7 Patients reported C1-esterase inhibitor (C1-INH) concentrate is an effective therapy in treating acute swelling attacks at any body location for HAE, a rare and serious genetic disorder, according to data presented today at the 2009 American College of Allergy, Asthma & Immunology (ACAAI) Annual Meeting. The results come from a self-reported su... [Comments]

Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity

11/7/2009

0

GOOD
MIAMI BEACH, Fla., Nov. 7 Most patients with hereditary angioedema (HAE) have prodromal symptoms that signal an oncoming HAE attack giving the patients sufficient time to initiate treatment and decrease the morbidity associated with that attack, according to survey findings presented today at the 2009 American College of Allergy, Asthma & Immunology (ACAAI) Annual Meeti... [Comments]

SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results

11/6/2009

0

GOOD
BOTHELL, Wash., Nov. 6 SCOLR Pharma, Inc. (Amex: DDD ) today reported financial results for the three and nine months ended September 30, 2009. Stephen J. Turner, SCOLR Pharma's President and CEO, said, "We continue to advance discussions related to licensing our 12-hour ibuprofen formulation. Several potential partners have committed significant resource... [Comments]

Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009

11/6/2009

0

GOOD
DURHAM, N.C., Nov. 6 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that a previously approved reverse split of its common stock will take effect at the start of trading on Monday, Nov. 9, 2009 on a 1-for-15 split-adjusted basis. Oxygen Biotherapeutics, Inc. shares will trade under the new symbol OXBT. The stock also will have a new CUSIP... [Comments]

Recession Continues to Depress Sales at Allied Healthcare Products

11/6/2009

0

GOOD
ST. LOUIS, Nov. 6 Recession in domestic and international markets continued to depress sales for Allied Healthcare Products in the first quarter of fiscal year 2010 ending September 30, 2009. Sales declines pushed Allied into a loss for the quarter. The net loss for the quarter was about $745,000, or negative 9 cents per share, compared to a net profit the... [Comments]

McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP

11/6/2009

0

GOOD
FORT WASHINGTON, Pa., Nov. 6 In consultation with the U.S. Food and Drug Administration (FDA), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is initiating a voluntary recall of a limited number of product lots of TYLENOL® Arthritis Pain Caplet 100 count bottles, with the distinctive red EZ-OPEN CAP. McNeil is initiating the recall after identifyin... [Comments]

DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

11/6/2009

0

GOOD
WILMINGTON, Mass., Nov. 6 DUSA Pharmaceuticals, Inc.(®) (Nasdaq GM: DUSA), a dermatology company that is developing and marketing Levulan(®) Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Merriman Curha... [Comments]

Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering

11/6/2009

0

GOOD
SAN DIEGO, Nov. 6 Trius Therapeutics, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company. Credit Suisse Securities (USA) LL... [Comments]

Watson to Present at Credit Suisse Healthcare Conference

11/6/2009

0

GOOD
MORRISTOWN, N.J., Nov. 6 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Credit Suisse 18th Annual Healthcare Conference on Wednesday, November 11, 2009 at 12:00 pm Eastern St... [Comments]

Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results

11/6/2009

0

GOOD
OAKLAND, Calif., Nov. 6 Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals (KFHP/H), and their subsidiaries reported today a combined total operating revenue of $10.5 billion for the quarter ended September 30, 2009, compared to $10.2 billion in the third quarter of last year. Operating income in the third quarter was $336 million, compared to $307 million in... [Comments]

[next]
(Date:11/7/2009)...NGTON, Nov. 7 With the ...ichoice extremists are holding the entire bill hos...e demanding that the bill go far beyond the status...orated into the original bill. In an outrageous a...aturday afternoon, antichoice Democrats are demand...
(Date:11/7/2009)...NGTON, Nov. 7 Speaker N...ailability this afternoon following a Democratic W...cus Room. Below are the Speaker,s opening remarks...was a great occasion for us to receive the Preside...e making history with our vote and making progress...
(Date:11/7/2009)...d not assume that all youth will rebel, expert say... Teens are more likely to behave badly if their pa..., "Parents who believe they are simply being reali...g prophecy," Christy Buchanan, a psychology profes... study, said in a university news release. "Negati...
(Date:11/7/2009)... In the current economic climate, man...ly and are only spending money on what that they c... loss surgeon David D. Kim believes that it&rsquo... women to receive treatment to improve their healt...fordable to patients in this tough economy by offe...
(Date:11/6/2009)...ME TSX: COM , VANCOUVER, Nov. 6 /PRNewswire-Fir...TSX: COM) today announced that it will report fina...r 30, 2009 on the morning of Monday, November 9, 2...webcast at 9:00am Eastern (6:00am Pacific) on that...erence call, please dial 416-695-7806 or 888-789-9...
Breaking Medicine News(10 mins):Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3
...he molecular level in the cells of the heart may b... findings, by researchers at The Ohio State Univer...itute, // show that specialized proteins called ry...art from contracting effectively and relaxing adeq...
...e Growth Factor-1 (IGF-1) is an important hormone ...in order for children's bones, cartilage and organ... hormone is // secreted into the bloodstream by th...into the bloodstream. Any defect in the above...
... at the University of California in San Francisco ...uit and vegetables can reduce the risk of pancreat...t strongly associated with increased // protection...vegetables. Light-green vegetables, tomatoes and t...
...ered by parents of newborns with craniofacial anom...chosocial development of their children. A ne.../ infant with a craniofacial anomaly (CFA) leads t...th the initial shock of learning of the CFA. Paren...
...rs and patients alike look forward to the day when...ormal genes by supplying the body with normal ones...c disorder by inserting // normal genes into abnor... of the normal gene to use in the treatment was no...
... 18 India and Pakistan maybe daggers drawn on many... many friends include the treatment in India of 70...t treatment. This one gesture is likely to p...to deliver in the last 50 years. These young...
Other Medicine News:Health News:Defect In Cardiac Cells Lead To Heart Failures 2Health News:Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement 2Health News:Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childr 2
LB Agarose Plates
LB Top Agarose 100ml Bottle
LB Agar (Bottle)
LB Broth with 7.5% Glycerol
Medicine Products:
(Date:11/6/2009)...Newswire-FirstCall/ -- Oxygen Biotherapeutics, Inc...a previously approved reverse split of its common ...Monday, Nov. 9, 2009 on a 1-for-15 split-adjusted ...ade under the new symbol OXBT. The stock also will...lit becomes effective. ,, "This reverse split w...
(Date:11/6/2009)...swire/ -- Trius Therapeutics, Inc. announced today...m S-1 with the U.S. Securities and Exchange Commis...ffering of shares of its common stock. All shares ...l be offered by the Company. ,, Credit Suisse S... manager, Piper Jaffray & Co. is acting as co-...
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Roper Industries, Inc. ... definitive agreement to acquire Verathon, Inc., a... The Verathon Board of Directors has approved the ...y regulatory approvals and closing conditions, inc...he closing to be completed in early December. ,...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 1ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 2ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 3GREENBioPharma Dec 2 3 2009 10591 1Whooping Cough Immunity Lasts 30 Years or More 60406 1Whooping Cough Immunity Lasts 30 Years or More 60406 2